vs
Royalty Pharma plc(RPRX)与Rackspace Technology, Inc.(RXT)财务数据对比。点击上方公司名可切换其他公司
Rackspace Technology, Inc.的季度营收约是Royalty Pharma plc的1.1倍($682.8M vs $622.0M),Royalty Pharma plc净利率更高(34.4% vs -4.8%,领先39.2%),Royalty Pharma plc同比增速更快(4.8% vs -0.4%),过去两年Royalty Pharma plc的营收复合增速更高(4.6% vs -0.6%)
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业,专注于研发可调节转化生长因子β(TGF-β)超家族蛋白的药物,该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
Rackspace Technology, Inc.是总部位于美国得克萨斯州圣安东尼奥的云计算企业,在弗吉尼亚州雷斯顿以及澳大利亚、加拿大、英国、印度、迪拜、瑞士、荷兰、德国、新加坡、墨西哥、中国香港等多个国家和地区设有办事处,数据中心分布于全球多个主要城市,为客户提供专业的云计算相关服务。
RPRX vs RXT — 直观对比
营收规模更大
RXT
是对方的1.1倍
$622.0M
营收增速更快
RPRX
高出5.2%
-0.4%
净利率更高
RPRX
高出39.2%
-4.8%
两年增速更快
RPRX
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $622.0M | $682.8M |
| 净利润 | $214.2M | $-32.7M |
| 毛利率 | — | 17.6% |
| 营业利润率 | 62.4% | -0.5% |
| 净利率 | 34.4% | -4.8% |
| 营收同比 | 4.8% | -0.4% |
| 净利润同比 | 2.9% | 41.6% |
| 每股收益(稀释后) | $0.49 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
RPRX
RXT
| Q4 25 | $622.0M | $682.8M | ||
| Q3 25 | $609.3M | $671.2M | ||
| Q2 25 | $578.7M | $666.3M | ||
| Q1 25 | $568.2M | $665.4M | ||
| Q4 24 | $593.6M | $685.6M | ||
| Q3 24 | $564.7M | $675.8M | ||
| Q2 24 | $537.3M | $684.9M | ||
| Q1 24 | $568.0M | $690.8M |
净利润
RPRX
RXT
| Q4 25 | $214.2M | $-32.7M | ||
| Q3 25 | $288.2M | $-67.1M | ||
| Q2 25 | $30.2M | $-54.5M | ||
| Q1 25 | $238.3M | $-71.5M | ||
| Q4 24 | $208.2M | $-56.0M | ||
| Q3 24 | $544.0M | $-186.6M | ||
| Q2 24 | $102.0M | $25.0M | ||
| Q1 24 | $4.8M | $-640.6M |
毛利率
RPRX
RXT
| Q4 25 | — | 17.6% | ||
| Q3 25 | — | 19.4% | ||
| Q2 25 | — | 19.4% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | — | 20.3% | ||
| Q2 24 | — | 19.2% | ||
| Q1 24 | — | 19.2% |
营业利润率
RPRX
RXT
| Q4 25 | 62.4% | -0.5% | ||
| Q3 25 | 70.1% | -5.1% | ||
| Q2 25 | 36.3% | -3.8% | ||
| Q1 25 | 94.0% | -5.8% | ||
| Q4 24 | 60.9% | -4.2% | ||
| Q3 24 | — | -25.7% | ||
| Q2 24 | 50.2% | -7.9% | ||
| Q1 24 | -13.0% | -94.5% |
净利率
RPRX
RXT
| Q4 25 | 34.4% | -4.8% | ||
| Q3 25 | 47.3% | -10.0% | ||
| Q2 25 | 5.2% | -8.2% | ||
| Q1 25 | 41.9% | -10.7% | ||
| Q4 24 | 35.1% | -8.2% | ||
| Q3 24 | 96.3% | -27.6% | ||
| Q2 24 | 19.0% | 3.7% | ||
| Q1 24 | 0.8% | -92.7% |
每股收益(稀释后)
RPRX
RXT
| Q4 25 | $0.49 | $-0.13 | ||
| Q3 25 | $0.67 | $-0.28 | ||
| Q2 25 | $0.07 | $-0.23 | ||
| Q1 25 | $0.55 | $-0.31 | ||
| Q4 24 | $0.46 | $-0.20 | ||
| Q3 24 | $1.21 | $-0.82 | ||
| Q2 24 | $0.23 | $0.11 | ||
| Q1 24 | $0.01 | $-2.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $618.7M | $105.8M |
| 总债务越低越好 | $9.0B | $2.7B |
| 股东权益账面价值 | $9.7B | $-1.2B |
| 总资产 | $19.6B | $2.8B |
| 负债/权益比越低杠杆越低 | 0.92× | — |
8季度趋势,按日历期对齐
现金及短期投资
RPRX
RXT
| Q4 25 | $618.7M | $105.8M | ||
| Q3 25 | $938.9M | $99.5M | ||
| Q2 25 | $631.9M | $103.9M | ||
| Q1 25 | $1.1B | $128.0M | ||
| Q4 24 | $929.0M | $144.0M | ||
| Q3 24 | $950.1M | $157.1M | ||
| Q2 24 | $1.8B | $190.2M | ||
| Q1 24 | $843.0M | $282.6M |
总债务
RPRX
RXT
| Q4 25 | $9.0B | $2.7B | ||
| Q3 25 | $8.9B | $2.8B | ||
| Q2 25 | $8.0B | $2.8B | ||
| Q1 25 | $7.6B | $2.8B | ||
| Q4 24 | $7.6B | $2.8B | ||
| Q3 24 | $7.6B | $2.8B | ||
| Q2 24 | $7.6B | $2.9B | ||
| Q1 24 | $6.1B | $3.0B |
股东权益
RPRX
RXT
| Q4 25 | $9.7B | $-1.2B | ||
| Q3 25 | $9.6B | $-1.2B | ||
| Q2 25 | $9.5B | $-1.1B | ||
| Q1 25 | $9.8B | $-1.1B | ||
| Q4 24 | $10.3B | $-1.0B | ||
| Q3 24 | $10.3B | $-949.7M | ||
| Q2 24 | $9.8B | $-756.2M | ||
| Q1 24 | $9.9B | $-787.2M |
总资产
RPRX
RXT
| Q4 25 | $19.6B | $2.8B | ||
| Q3 25 | $19.3B | $2.8B | ||
| Q2 25 | $18.3B | $2.9B | ||
| Q1 25 | $17.6B | $3.0B | ||
| Q4 24 | $18.2B | $3.1B | ||
| Q3 24 | $18.0B | $3.1B | ||
| Q2 24 | $17.7B | $3.4B | ||
| Q1 24 | $16.1B | $3.5B |
负债/权益比
RPRX
RXT
| Q4 25 | 0.92× | — | ||
| Q3 25 | 0.93× | — | ||
| Q2 25 | 0.84× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.74× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $827.1M | $59.7M |
| 自由现金流经营现金流 - 资本支出 | — | $56.0M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 3.86× | — |
| 过去12个月自由现金流最近4个季度 | — | $90.6M |
8季度趋势,按日历期对齐
经营现金流
RPRX
RXT
| Q4 25 | $827.1M | $59.7M | ||
| Q3 25 | $702.6M | $70.7M | ||
| Q2 25 | $364.0M | $8.4M | ||
| Q1 25 | $596.1M | $12.6M | ||
| Q4 24 | $742.5M | $54.3M | ||
| Q3 24 | $703.6M | $51.8M | ||
| Q2 24 | $658.2M | $24.1M | ||
| Q1 24 | $664.6M | $-90.3M |
自由现金流
RPRX
RXT
| Q4 25 | — | $56.0M | ||
| Q3 25 | — | $42.7M | ||
| Q2 25 | — | $-12.4M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | — | $34.4M | ||
| Q3 24 | — | $27.3M | ||
| Q2 24 | — | $-14.5M | ||
| Q1 24 | — | $-118.4M |
自由现金流率
RPRX
RXT
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | -1.9% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | -2.1% | ||
| Q1 24 | — | -17.1% |
资本支出强度
RPRX
RXT
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 3.1% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 4.1% |
现金转化率
RPRX
RXT
| Q4 25 | 3.86× | — | ||
| Q3 25 | 2.44× | — | ||
| Q2 25 | 12.06× | — | ||
| Q1 25 | 2.50× | — | ||
| Q4 24 | 3.57× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 6.45× | 0.96× | ||
| Q1 24 | 139.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
RXT
| Public Cloud Services Segment | $442.2M | 65% |
| Private Cloud Service Segment | $240.6M | 35% |